Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
x.labs was a private U.S. technology company that developed public safety threat-detection products and digital healthcare screening tools. Its best-known healthcare-related offerings were touchless elevated-temperature screening products marketed during the COVID-19 era, including the FEEVR system and related screening workflows. The company appears to have operated primarily as a commercial product company rather than a drug developer, with no evidence of a therapeutic pipeline or clinical-stage biopharma assets. Available business-directory sources describe the company as founded in 2018, headquartered in West Hollywood, California, and later closed. Overall, x.labs fits better as a healthtech and safety technology vendor than as a biotech, pharma, or life sciences therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on x.labs.